tidines have been synthesized via a ring opening of 1-azabicyclo-
[1.1.0]butanes with Olah’s reagent (pyridine.10 HF) or liquid
hydrogen fluoride.12 Although good yields were obtained for
the ring opening, the drawback of this synthesis is the use of a
multistep preparation of the labile starting material, that is,
1-azabicyclo[1.1.0]butanes. A very peculiar example of a
reduction of a 3-fluorinated â-lactam with diisobutyl aluminum
hydride toward the corresponding 3-fluoro-2-azetidinol is also
known.13 At present, a rapidly growing interest in 3-fluorinated
azetidines exists, as these compounds apparently possess
interesting biological activities. The inhibition of specific
enzymes such as dipeptidyl peptidase IV constitutes a promising
feature of fluorinated azetidines which can be applied in the
treatment of type 2 diabetes.14-18 In addition, the recent patents
concerning fluorinated azetidines emphasize the possibilities of
these compounds as substituents to modulate the activity of
different active compounds.19-22 In the latter publications,
3-fluorinated azetidines are mainly synthesized by treatment of
3-azetidinols or 3-azetidinones with diethylaminosulfur trifluo-
ride (DAST). Until now, this synthetic method is the only
procedure to obtain 3-fluorinated azetidines. However, no
examples of the synthesis of 3- or 4-substituted 3-fluoroaze-
tidines via this method are known. As a result, new syntheses
toward the highly attractive 3-fluoroazetidines are of consider-
able interest for organic, agrochemical, and medicinal chemists.
Synthesis of 3-Fluoroazetidines
Willem Van Brabandt, Guido Verniest,† Dirk De Smaele,
Guillaume Duvey, and Norbert De Kimpe*
Department of Organic Chemistry, Faculty of Bioscience
Engineering, Ghent UniVersity, Coupure links 653, B-9000
Ghent, Belgium
ReceiVed May 29, 2006
N-(Alkylidene or 1-arylmethylidene)-2-propenylamines were
regiospecifically functionalized to novel N-(alkylidene or
1-arylmethylidene)-3-bromo-2-fluoropropylamines, which
were proven to be excellent precursors for 3-fluoroazetidines.
Introduction
The selective fluorination of biologically important com-
pounds often results in a profound modification of their
biological activity.1-3 These distinctive properties of specifically
fluorinated compounds have significantly contributed to the
growing interest in the field of organofluorine chemistry in the
past decade. Although â-fluorinated amines have been the
subject of considerable attention because of their interesting
pharmaceutical properties,1-3 their small ring heterocyclic
analogues have barely been described in the literature. 3-Mono-
fluorinated azetidines are very rare compounds, the chemistry
of which is virtually unknown, apart from some isolated
transformations. Perfluoroazetidines have been prepared by
thermolysis of the corresponding perfluoro-1,2-oxazines or by
photolysis of perfluorinated triazines,4-7 while 3-fluoroazetidine
N-oxides have been involved in the synthesis of isoxazolidines
via thermal ring enlargement.8 Photofluorination of azetidines
with fluoroxytrifluoromethane has been used in the preparation
of L-cis-3-fluoroazetidine-2-carboxylic acid.9-11 3-Fluoroaze-
Results and Discussion
In the present article, we report an efficient and facile three-
step procedure for the synthesis of 3-fluoroazetidines 4 and 11
using N-(alkylidene or 1-arylmethylidene)-γ-bromo-â-fluoro-
amines 3. Imines bearing reactive halogens in the side chain
have not been frequently used in organic synthesis because of
the lability of this type of bifunctional compounds. However,
(9) Kollonitsch, J.; Barash, L.; Doldouras, G. A. J. Am. Chem. Soc. 1970,
92, 7494.
(10) Kollonitsch, J. U.S. Patent 4030994 21/06/1977; Chem. Abstr. 1977,
88, 83904.
(11) Kollonitsch, J. Ger. Offen. 1972, DE 2136008 10/02/1972; Chem.
Abstr. 1972, 76, 154488.
(12) Alvernhe, G.; Laurent, A.; Touhami, K.; Bartnik, R.; Mloston, G.
J. Fluorine Chem. 1985, 29, 363.
(13) Araki, K.; O’Toole, J. C.; Welch, J. T. Bioorg. Med. Chem. Lett.
1993, 3, 2457.
(14) Parker, J. C.; Hulin, B. U.S. Pat. Appl. Publ. US 2005043292 A1
24/02/2005; Chem. Abstr. 2005, 142, 261783.
(15) Li, W.; Oliver, E., Jr.; Rojas, C.; Kalish, V.; Belyakov, S. PCT Int.
Appl. WO 2004071454 A2 26/08/2004; Chem. Abstr. 2004, 141, 225299.
(16) Duffy, J. L.; Mathvink, R. J.; Weber, A. E.; Xu, J. PCT Int. Appl.
WO 2004050022 A2 17/06/2004; Chem. Abstr. 2004, 141, 54612.
(17) Colandrea, V. J.; Edmondson, S. D.; Mathvink, R. J.; Mastracchio,
A.; Weber, A. E.; Xu, J. PCT Int. Appl. WO 2004043940 A1 27/05/2004;
Chem. Abstr. 2004, 141, 7438.
(18) Hulin, B.; Parker, J. C. PCT Int. Appl. WO 2003101958 A2 11/
12/2003; Chem. Abstr. 2003, 140, 16965.
(19) Ge, P.; Horvath, R. F.; Zhang, L. Y.; Yamaguchi, Y.; Kaiser, B.;
Zhang, X.; Zhang, S.; Zhao, H.; John, S.; Moorcroft, N.; Shutske, G. PCT
Int. Appl. WO 2005023806 A2 17/03/2005; Chem. Abstr. 2005, 142,
261783.
* To whom correspondence should be addressed. Tel: +32 (0)9 264 59 50.
Fax: +32 (0)9 264 62 43.
† Postdoctoral Fellow of the Research Foundation Flanders (FWO-Vlaan-
deren).
(1) Welch, J. T. Tetrahedron 1987, 43, 3123.
(2) Welch, J. T.; Eswarakrishnan, S. Fluorine in Bioorganic Chemistry;
John Wiley & Sons: New York, 1991.
(3) Smart, B. J. Fluorine Chem. 2001, 109, 3.
(4) Banks, R. E.; Barlow, M. G.; Haszeldine, R. N. J. Chem. Soc. 1965,
6149.
(5) Banks, R. E.; Haszeldine, R. N.; Matthews, V. J. Chem. Soc. C 1967,
2263.
(6) Yamamoto, T.; Yasuhara, A.; Shiraishi, F.; Kaya, K.; Abe, T.
Chemosphere 1997, 35, 643.
(7) Chambers, R. D.; Shepherd, T.; Tamura, M. J. Chem. Soc., Perkin
Trans. 1 1990, 4, 975.
(20) Brooks, D. P. PCT Int. Appl. WO 2005000311 A1 06/01/2005;
Chem. Abstr. 2005, 142, 114098.
(21) Flohr, A.; Norcross, R. D. U.S. Pat. Appl. Publ. US 2004204584
A1 14/10/2004; Chem. Abstr. 2004, 141, 350158.
(8) Suzuki, Y.; Watanabe, T.; Tsukamoto, K.; Hasegawa, Y. Ger. Offen.
2, 317, 980 (Cl. C07d), October 31, 1973, Japan. Appl. 72 35, 123, April
10, 1972; Chem. Abstr. 1973, 80, 37092j.
(22) Churcher, I.; Harrison, T.; Kerrad, S.; Oakley, P. J.; Shaw, D. E.;
Teall, M. R.; Williams, S. PCT Int. Appl. WO 2004031137 A1 15/04/2004;
Chem. Abstr. 2004, 140, 321108.
10.1021/jo061095b CCC: $33.50 © 2006 American Chemical Society
Published on Web 08/05/2006
7100
J. Org. Chem. 2006, 71, 7100-7102